CellaVision AB

Rapporter

Visar 2 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Performance

    • Net sales for the first quarter decreased by 15% to SEK 166 million (195), with organic sales growth of -6.6% (+14.1).
    • EBITDA amounted to SEK 40 million (66), corresponding to an EBITDA margin of 24% (34).
    • Profit before tax was SEK 28 million (53), and earnings per share before and after dilution were SEK 0.94 (1.74).
    • Cash flow from operating…

    Öppna rapport

  2. Årsredovisning 2025

    SV
    →

    | Nyckeltal (MSEK) | 2025 | 2024 | | :--- | :--- | :--- | | Nettoomsättning | 759 | 723 | | Bruttoresultat | 520 | 487 | | EBITDA | 219 | 219 | | EBITDA-marginal | 29% | 30% | | Rörelseresultat | 202 | 178 | | Årets resultat | 153 | 141 | | Kassaflöde från den löpande verksamheten | 201 | 198 | | Resultat per aktie (SEK) | 6,42 | 5,90 |

    Öppna rapport